Lifestyle intervention programs currently emphasize weight loss secondary to obesity as the primary determinant of phenotypic changes. We examined whether the effects of a short-term 
Obesity is associated with a variety of chronic diseases, including, but not limited to coronary artery disease, hypertension, diabetes and certain forms of cancer. In the US, 34% of adolescents ages 12 to 19 years of age are classified as "overweight" or "obese" (BMI > 85 th percentile) (13) .
Unhealthy lifestyle factors, such as physical inactivity/lack of exercise training, and highrefined-carbohydrate, high-fat diet consumption begin in childhood and contribute to both the development of obesity and other chronic diseases (17) , and thus it is unclear whether obesity per se or the associated lifestyle factors are underlying causes of the cardiovascular and metabolic dysfunction and the related development of chronic disease.
The first line of defense against obesity-related disease has been weight loss, as the currently held view in lifestyle intervention programs emphasizes that weight loss secondary to obesity is the primary determinant of phenotypic changes (16, 23) . However, it is unclear if obesity and the subsequent weight loss are the primary drivers of the phenotypic modifications. Along these lines, we previously demonstrated reversal of metabolic syndrome (4) and amelioration of a variety of atherosclerotic (18) and metabolic (10) risk factors, including markers of endothelial dysfunction, oxidative stress, inflammation and fatty acid species in overweight/obese youth with lifestyle modification. As the intervention was short-term, this allowed us to study lifestyle effects prior to reversal of obesity. The changes occurred despite small changes in weight, and correlation analysis indicated that changes in phenotypic markers were independent of weight loss. These findings suggested that lifestyle changes may be the underlying drivers of changes in metabolic and cardiovascular phenotypes. This led us to test the validity of overweight/obesity status as a primary cause of metabolic abnormalities by investigating the effects of an identical lifestyle intervention in normal weight compared with overweight/obese children.
Thus, the present study was designed to examine the efficacy of a short-term, daily exercise and plant-based ad libitum diet intervention program on serum endocrine and cytokine markers. We examined its effects on interleukin (IL)-8, IL-10, IL-1 receptor antagonist ((IL-1ra), IL-6, tumor necrosis factor-α (TNF-α), plasminogen activator-inhibitor (PAI)-1, resistin, amylin and leptin differs in normal weight versus obese children. We hypothesized that normal weight and obese children would respond similarly to the lifestyle intervention program irrespective of baseline obesity status, suggesting that dietary intake and lack of exercise/physical activity are the underlying causes of the phenotypic abnormalities noted.
Methods

Subjects
Normal weight and overweight/obese children (classified by the CDC sex-specific BMI-for-age percentiles) voluntarily participated in the Pritikin Longevity Center 2-week residential lifestyle modification program where a plant-based diet was provided ad libitum and daily exercise (2-2.5 hr) was performed. All subjects in the O group had a BMI >85 th percentile and 13 of the 19 were >95 th percentile (obese) according to CDC BMI-for-age percentile standards. All 14 subjects in the N group were considered to be at a healthy weight (>5th and <85th percentile), according to CDC guidelines.
None of the subjects were using drugs or therapies for obesity, and none had prior histories of disease or injury that would prevent daily exercise. Consent to participate in a research program was obtained from the parents; all agreed to provide data for the study, and the project was approved by the University of California, Los Angeles Institutional Review Board.
Diet and Exercise Intervention
Participants in the program received a complete physical examination and underwent a 14-day diet and exercise intervention as previously described (4, 10, 18 gym-based exercises, swimming, tennis, and beach games, intended to encourage physical activity in the subjects. Blood samples were drawn after a 12-hour overnight fast on days 1 and 12 of the intervention. The blood was separated by centrifugation and serum was shipped on dry ice to UCLA where it was stored at -80ºC until analysis. Height and body weight were used to calculate BMI and were also assessed on these days using a stadiometer and calibrated scale.
BMI was calculated as weight (kg)/height (m 2 ).
Determination of Serum Lipids, Glucose, Insulin, HOMA-IR, and QUICKI Total cholesterol, triglycerides (TG), high-density lipoprotein (HDL), and glucose levels were measured at a national commercial laboratory (Quest Diagnostics, Miami, FL) using standardized techniques. Low-density lipoprotein (LDL) was calculated as described by the Friedewald formula (7). Total-cholesterol/HDL and LDL/HDL ratios were also calculated.
Insulin was quantified in duplicate using Luminex xMAP Multiplex (Millipore, Billerica, MA).
The degree of insulin resistance was estimated with the use of the homeostatic model assessment for insulin resistance (HOMA-IR), calculated as the product of the fasting plasma insulin level (µU/ml) and the fasting plasma glucose level (mmol/L), divided by 22.5. Insulin sensitivity was also estimated by the quantitative insulin-sensitivity check index (QUICKI), as defined by 1/(log[fasting insulin (µU/ml)] + log[fasting glucose (mg/dl)]).
Determination of Serum Cytokines and Metabolic Markers
Serum IL-8, IL-10, IL-1ra, IL-6, TNF-α, PAI-1, resistin, amylin and leptin were measured in duplicate using specific Luminex xMAP Multiplex kits (Millipore, Billerica, MA) according to the manufacturer's instructions. Serum adiponectin (ACRP) was measured in duplicate using enzyme-linked immunosorbent assay (ELISA) kits (R&D Systems, Minneapolis, MN). For a particular assay, all subject samples were assayed on the same day and according to the kit inserts recovery was generally 85-112% and the coefficient of variation <10%.
Statistical Analysis
Statistical analyses were performed with Graph Pad Prism (GraphPad, San Diego, CA) and
STATA (StataCorp, College Station,TX). Pearson correlations between changes in
anthropometrics and metabolic markers were performed in Prism. To determine the effect of the intervention for each group and compare the changes between the normal weight and obese group we used a linear mixed model for repeated measures in STATA. All data are expressed as mean ± SE unless otherwise noted. A p value of < 0.05 was considered statistically significant.
Results
Anthropometric Characteristics, Blood Pressure, Lipids, Glucose and Insulin (Table 1) Anthropometric and metabolic data are summarized in 4.9%, p=0.12) increased significantly in both groups, p<0.01, mainly driven by the decrease in insulin.
Cytokines, Adipokines and Endocrine Markers (Figures 1, 2 and 3)
All biomarkers were similar at baseline between the two groups except for PAI-1 (p<0. 
Discussion
Currently there is the perception that obesity is causally implicated in the pathogenesis of dyslipidemia, insulin resistance, inflammation, and other features related to metabolic health. It is certainly the case that adipose tissue, depending on location and characteristics, may exacerbate various risk factors. For example, it is well-established that visceral fat contributes to worsening of metabolic health (6, 25) . However, if obesity is the primary cause, then: 1) reversal of obesity would be required to reverse phenotypic abnormalities, and 2) subjects who were not obese would not respond similarly to obese subjects. Regarding the first point, in previous seminal studies, we demonstrated that short-term lifestyle modification could ameliorate metabolic syndrome phenotypes in both men (19) and children (10). In addition, a variety of cardiovascular disease risk factors were improved in men (19, 20) , women (28) and children (4, 18) , despite modest weight loss and subjects remaining overweight/obese by BMI classification.
Furthermore, when we correlated changes in body weight or BMI with changes in phenotypic outcomes, no significant associations were noted. We did, however, find significant correlations between various fatty acid species and inflammatory factors (10).
Regarding the second point, the present study was designed to test the hypothesis that responsiveness to a short-term, daily physical activity and plant-based ad libitum diet intervention program would be similar between normal weight and overweight/obese children.
An advantage of using a short-term intervention is that lifestyle changes can be assessed independent of obesity reversal. The findings of the current study indicated that effects were similar in both overweight/obese and normal weight subjects. This occurred even for metabolic outcomes that exhibited significant differences at baseline (PAI-1, leptin, and IL-1ra).
Furthermore, the normal weight subjects had similar responses in measured phenotypes/metabolic markers to the overweight/obese subjects despite not being overweight/obese at baseline or exhibiting weight loss. The potential contributing lifestyle factors involved in the changes seen in the metabolic profile have been discussed previously (10) and likely include the decrease in saturated/trans fats and refined-sugar consumption and the increase in omega-3 fatty acids and nutrients (vitamins, minerals, phytochemicals, and fiber) from the diet, and the increase in physical activity, all of which can alter inflammatory and oxidative processes. Interestingly, the changes in serum cytokines, adipokines and endocrine markers were not associated with changes in body weight, BMI or waist circumference in either group. One explanation for the similar effect is that both the normal weight and obese subjects improve phenotypes related to lipid levels, insulin resistance, adipokines, etc., but the obese subjects have a genetic predisposition (1) to gain weight more readily compared with normal weight subjects. It is known that many obese subjects are not metabolically unhealthy (24), while many normal weight individuals (by BMI) are metabolically unhealthy (29). Thus, longterm, it is possible that with continued lifestyle modification obesity may be reversed, but even if not, a metabolically healthy, obese phenotype can develop, as was noted in the short-term with the obese subjects enrolled in the current study. Furthermore, given that weight loss attempts are typically associated with a high-degree of recidivism in adult and pediatric populations (5, 8) ;
lifestyle modification that focuses on the normalization of metabolic phenotypes may be of significant value in the pediatric population.
The noted benefits on metabolic, cardiovascular and inflammatory biomarkers independent of weight loss are not surprising, and it is apparent that the relationships between body weight and lifestyle are complex. For example, Phillips et al. (15, 27) provided different diets to obese young adults and noted that despite both groups exhibiting significant weight loss and decreased blood pressure, a "low-fat" diet improved, while a "low-carbohydrate" diet worsened endothelial function. In addition, Bradley et al. (3) noted that a low-fat diet improved, while a lowcarbohydrate diet worsened augmentation index. Petersen's group (11, 14) noted that with a short-term decrease in daily physical activity there was decreased insulin sensitivity and aerobic fitness, despite modest weight loss. Interestingly, in the Diabetes Prevention Program, those who only met the physical activity goal, but not the weight loss goal had a 44% decrease in diabetes incidence (9) , while in the Finnish Diabetes trial achieving 4 hours/week of physical activity led to a reduction in diabetes risk in subjects who did not lose weight (26) .
Also of interest in our cohort is the fact that baseline and percent change in several of the biomarkers were similar in normal weight and obese children, suggesting similar cardiovascular disease risk profiles. The Pathobiological Determinants of Atherosclerosis in Youth study demonstrated coronary atherosclerosis in both normal weight and obese males but more severe in the obese (12) . It is possible that the mechanisms by which normal weight and obese subjects improve in an intervention of this type differ; however, this would require further investigation using molecular techniques to establish potential differences.
The current study has important strengths and limitations to consider. The major strength of the study is the monitoring permitted by the study. Monitoring food intake and physical activity reduces the need to query subjects about their compliance or to rely on food and activity questionnaires. Further, all exercise sessions were supervised facilitating adherence to the diet and activities. Additionally, the diet was ad libitum -a major advantage in cases where overeating is an issue -and thus, this is a more realistic program to implement into the daily lives of children rather than intentional caloric restriction. A limitation of the present study is the lack of body composition data to determine the fat mass and lean mass of both groups.
Additionally, we did not look at diet and exercise independently and therefore cannot attribute the changes directly to either aspect of the intervention.
Overall, short-term, intensive lifestyle modification is effective in ameliorating several metabolic risk factors similarly in both normal weight and overweight/obese children. Furthermore, because the normal weight children were not obese and we did not find any associations between changes in indices of obesity and our serum measures; baseline obesity or weight loss per se
were not the primary drivers leading to the phenotypic changes noted. These findings suggest that dietary intake and exercise/physical activity changes may be the underlying causes of the phenotypic changes noted. Additionally, the normal weight subjects exhibited metabolic abnormalities, likely due to their ongoing diet and lifestyle habits. Even though current public health recommendations are centered on overweight/obesity and the metabolic abnormalities associated with the same, we have demonstrated that there may be room for improvement in the metabolic profiles of individuals who are not overweight/obese. Given that body weight and weight change are poor surrogates for lifestyle (2) , these findings reinforce the need to remind even normal weight individuals about healthy lifestyle choices. Furthermore, therapies driven by BMI classification and weight loss in young patients may lead to missed opportunities to counsel them on the benefits of weight loss-independent effects of lifestyle modification, including
proper diet and physical activity (21, 22) . Overall, the results support the need for larger, randomized, long-term studies to investigate the impact of lifestyle modification on disease outcomes independent of weight loss.
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